It has been reported that high EphB4 expression enhanced the growth and migration of pancreatic, colorectal and papillary thyroid carcinoma, and such effect could be reversed by EphB4 knockdown, making EphB4 a promising target for cancer treatment14–16. Here, EPHB4 is linked to differentiated thyroid carcinoma.